SecBot SecBot
SECBOTREPLAY Home › Report › TNGX

TNGX · Matthew Gall, CFO of Tango Therapeutics, filed a Form 3 and granted a…

Tango Therapeutics, Inc. · 3 filed Apr 24, 2026 at 16:15 ET

At the news

NEUTRALIMPACT 2/10

3 filed Apr 24, 2026 at 16:15 ET

Matthew Gall, CFO of Tango Therapeutics, filed a Form 3 and granted a power of attorney to Julie Fogarty to file SEC reports on his behalf, including Forms 3, 4, and 5. This is a routine compliance filing related to insider reporting obligations.

  • Matthew Gall, CFO of Tango Therapeutics, filed a Form 3 indicating initial beneficial ownership reporting.
  • He granted power of attorney to Julie Fogarty to file Forms 3, 4, and 5, Schedule 13D/G, and amendments on his behalf.
  • The filing was made effective as of April 24, 2026, with a report date of April 15, 2026.
  • No transaction or change in beneficial ownership was disclosed; this is an administrative filing.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access